Tempus AI Inc Class A common stock TEM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
CellCarta Adds Tempus to CDx Commercialization Lab Network
-
Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications
-
Tempus Reports Second Quarter 2026 Results
-
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed
-
Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine
-
Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform
-
Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service
-
Tempus to Report Second Quarter 2026 Financial Results on July 30
Trading Information
- Previous Close Price
- $55.06
- Day Range
- $53.00–56.58
- 52-Week Range
- $40.77–104.32
- Bid/Ask
- $55.40 / $55.59
- Shares Outstanding
- 180.43M
- Market Cap
- $10.05B
- Volume/Avg
- 4M / 6M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 6.92
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 3,800
- Website
- https://www.tempus.com
Valuation
|
Metric
|
TEM
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 22.56 |
Price/Sales | 6.92 |
Price/Cash Flow | 654.31 |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
TEM
|
|---|---|
Quick Ratio | 3.05 |
Current Ratio | 3.30 |
Interest Coverage | −3.88 |
Quick Ratio
TEM
Profitability
|
Metric
|
TEM
|
|---|---|
Return on Assets (Normalized) | −5.83% |
Return on Equity (Normalized) | −28.69% |
Return on Invested Capital (Normalized) | −5.18% |
Return on Assets
TEM
Health Information Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A
VEEV
| LOCK|&v%jc<? | LOCK|rVC | $38B | |||
| Pro Medicus Ltd ADR
PMDIY
| — | LOCK|<Mx!v | $13B | |||
| Pro Medicus Ltd
PMCUF
| — | LOCK|^#qBt | $13B | |||
| BrightSpring Health Services Inc
BTSG
| — | LOCK|nk$Dh | $11B | |||
| HealthEquity Inc
HQY
| — | LOCK|bZN^X | $9B | |||
| 10x Genomics Inc Ordinary Shares - Class A
TXG
| — | LOCK|KsYSD | $8B | |||
| Hinge Health Inc Ordinary Shares - Class A
HNGE
| — | LOCK|^sN | $7B | |||
| M3 Inc ADR
MTHRY
| — | LOCK|M?PP | $7B | |||
| Waystar Holding Corp
WAY
| — | LOCK|?P | $5B |
United States